Should You Add Sun Life Financial to Your Dividend Portfolio?

NYSE: SLF | Sun Life Financial Inc. News, Ratings, and Charts

SLF – Sun Life Financial’s (SLF) high dividend yield could be attractive to income investors, but the company reported a decline in its revenue, earnings, and ROE. Also, analysts expect its EPS to decline in the current quarter. So, will it be an ideal stock to add to your dividend portfolio? Read on to learn our view…

Headquartered in Toronto, Canada, Sun Life Financial Inc. (SLF) is a financial services company that provides insurance, wealth, and asset management solutions to individuals and corporate clients worldwide.

It offers term and permanent life, personal health, dental, critical illness, long-term care, and disability insurance products. 

The company also provides reinsurance products, investment counseling and portfolio management services, mutual funds and segregated funds, trust and banking services, real estate property brokerage and appraisal services, and merchant banking services.

SLF’s four-year average dividend yield is 3.7%, and its current dividend translates to a 4.3% yield. It has declared a $0.69 per share quarterly dividend, which will be paid on June 30, 2022.

SLF’s revenue, underlying net income, and EPS decreased year-over-year in the last reported quarter.

Moreover, its underlying ROE came in at 14%, declining from 15.3% in the year-ago period. 

The company’s poor quarterly results led to its shares declining 11.3% in price year-to-date and 7.2% over the past year to close the last trading session at $49.40.

It is currently trading 15.5% below its 52-week high of $58.49, which it hit on February 9, 2022.

Here’s what could influence SLF’s performance in the upcoming months:

Disappointing Financials

SLF’s total revenue declined 74.9% year-over-year to C$380 million ($301.25 million) for the first quarter ended March 31, 2022. 

The company’s net income declined 8.4% year-over-year to C$858 million ($680.19 million). Also, its EPS came in at C$1.44, compared to C$1.45 in the year-ago period.

Mixed Analyst Estimates

Analysts expect SLF’s EPS for the quarter ending June 30, 2022, to decline 2.5% year-over-year to $1.16. Its revenues for fiscal 2022 and 2023 are expected to increase 6.9% and 4%, respectively.

 It surpassed Street EPS estimates in each of the trailing four quarters.

Mixed Valuation

In terms of forward EV/S, SLF’s 1.14x is 59.6% lower than the 2.82x industry average. Likewise, its 9.75x forward EV/EBIT is 11% lower than the 10.96x industry average. 

However, the stock’s 1.48x forward P/B is 30.8% higher than the 1.13x industry average. Also, its 10.48x trailing-12-month non-GAAP P/E is 2.4% higher than the 10.23x industry average.

Mixed Profitability

SLF’s trailing-12-month gross profit margin and net profit margin of 41.48% and 11.43% are lower than the 64.46% and 29.09% industry average, respectively. 

Likewise, its 1.20% trailing-12-month ROA is 4.5% lower than the 1.25% industry average. 

Furthermore, the stock’s trailing-12-month asset turnover ratio of 0.11% is lower than the industry average of 0.21%. 

In addition, its trailing-12-month ROCE and Return on Total Capital of 15.80% and 9.57% are 25.9% and 58% higher than the industry averages of 12.55% and 6.05%, respectively.

POWR Ratings Reflect Uncertainty

SLF has an overall rating of C, equating to a Neutral in our POWR Ratings system. 

The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight different categories. SLF has a C grade for Value, in sync with its mixed valuation.

It has a C grade for Quality, consistent with its mixed profitability. In addition, the decline in its revenue and earnings justifies the D grade for Growth.

SLF is ranked #23 out of 55 stocks in the Insurance – Property & Casualty industry. Click here to access SLF’s Momentum, Stability, and Sentiment ratings.


SLF shares closed at $47.88 on Friday, down $-1.52 (-3.08%). Year-to-date, SLF has declined -12.20%, versus a -17.67% rise in the benchmark S&P 500 index during the same period.


About the Author: Dipanjan Banchur


Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SLFGet RatingGet RatingGet Rating
WRBGet RatingGet RatingGet Rating
LGet RatingGet RatingGet Rating
DGICAGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Investors: Why Are You So Bullish???

It’s easy to ignore bad news when the S&P 500 (SPY) is making new highs and our net worth is on the rise. Unfortunately it is often at these heights that the first signs of trouble appear...but are hard to see at first. That is why you need to read the latest insights from veteran investor, Steve Reitmeister, as he points to a disconnect between the fundamentals and current stock price action. Read on below for more...

Top 3 Tech Stocks With the Potential to Make Massive Returns

With continued technological innovation, the transformation of industries, and evolving needs of consumers and businesses, the technology industry is poised for significant growth and expansion. Hence, it could be wise to buy fundamentally strong tech stocks Dell Technologies (DELL), Teledyne Technologies (TDY), and Leidos Holdings (LDOS) for massive returns. Keep reading...

Top Rated Tech Stocks to Buy in March for Value

Fueled by technological advancements and increasing digitalization across diverse sectors, the tech industry is well-positioned to grow substantially in the future. Given this backdrop, fundamentally strong tech stocks Canon (CAJPY), Zoom Video Communications (ZM), Hewlett Packard Enterprise Company (HPE), and AUO Corporation (AUOTY) could be valuable buys in March. Read on…

3 Biotech Stocks to Watch in March for Success

The biotech industry is set for strong growth amid the growing need for personalized treatments, the rising number of chronic diseases, increased investment in research, and the use of advanced technologies. Therefore, investors could consider adding fundamentally strong biotech stocks Acorda Therapeutics (ACOR), BioNTech (BNTX), and Jazz Pharmaceuticals (JAZZ) to their watchlist. Read more...

Does This Chart Point to a Stock Correction?

Many seasoned investors are getting a bit concerned about stocks surging to 5,100 for the S&P 500 (SPY). That’s because earnings growth is nearly non-existent and thus stock prices are getting to elevated levels. This could point to a nasty correction ahead. That is why you will want to tune into Steve Reitmeister’s most up to date market commentary along with trading plan and top picks. Read on below for the full story...

Read More Stories

More Sun Life Financial Inc. (SLF) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SLF News